Finding and fueling tomorrow’s advances in precision medicine.
Joined April 2017
- Tweets 289
- Following 102
- Followers 323
- Likes 722
19 Photos and videos
Nextech retweeted
2 May 2024
Today, we announced a $100 million private placement. This financing, together with Context's existing cash and cash equivalents, is expected to extend our cash runway into 2028. $CNTX ir.contexttherapeutics.com/n…
2
14
2,252
Nextech retweeted
1 Aug 2023
1
2
3,257
28 Jun 2023
1
3
536
Nextech retweeted
26 Jun 2023
Congrats @oricpharma
and @JacobChackoMD on closing this PIPE. It also marks @NextechInvest first PIPE investment. We are excited about working together with this very talented team to advance the high potential pipeline
globenewswire.com/news-relea…
1
3
2,213
Nextech retweeted
3 May 2023
Congratulations to Fred Hutch's Dr. Phil Greenberg on his election to @theNASciences! Greenberg is an internationally-recognized expert in cancer #immunotherapy, a form of therapy that aims to harness the power of immune cells to eliminate #cancer. bit.ly/3AQpjwj
1
4
66
9,362
22 Dec 2022
Thank you @Nasdaq for highlighting our recent financing of Alpha-9. Great team, science and syndicate!
1
2
590
Nextech retweeted
23 Nov 2022
"I think success is having a career where you enjoy it so much that you almost feel guilty that people pay you to do it because you are having so much fun every day."
Wise words by our 2019 medicine laureate William Kaelin.
#NobelPrize
11
226
759
Nextech retweeted
16 Sep 2022
Farewell to our latest graduate, Dr. @StellaPaff, and best of luck for her next endeavor @NextechInvest! #LoweLab25
1
1
46
Nextech retweeted
15 Sep 2022
So grateful for the incredible LPs who joined our healthcare SIG this afternoon and shared how venture firms can create value, promote ongoing engagement, and prioritize LP's unique motivations. Shout out to our moderator, Melisa McCracken of @NextechInvest 👋🏽🔥
1
3
IDRx is starting off with $122 million and two licensed drug candidates it plans to combine to create a treatment for gastrointestinal stromal tumors, or GIST. buff.ly/3zqDHu3
3
4
Nextech retweeted
2 Aug 2022
Startup IDRx raises $122m to focus on combination drug treatments trib.al/u6x54bm
3
1
Nextech retweeted
2 Aug 2022
IDRx is launching w/ $122m to treat cancer with ‘purpose-built’ precision combination therapies.
@a16z is thrilled to co-lead this financing w/ @cascapital participation from @NextechInvest, Forge Life Science Partners & other investors.
idrx.com/press-releases/idrx…
1
3
6
Nextech retweeted
1 Aug 2022
At Arrakis, we have a simple but powerful vision: To extend medicines into new realms of biology by discovering and developing rSMs (RNA-targeted small molecules) that act directly on RNA to treat disease. Happy #RNADay!
1
10
Nextech retweeted
18 Jul 2022
We are thrilled to announce our collaboration with Merck to evaluate PC14586 in combination with Merck’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in patients with advanced solid tumors.
globenewswire.com/news-relea…
#p53 #oncology
2
2
Nextech retweeted
17 May 2022
Please join us in congratulating our Co-Founder, Luc Brunsveld, on his election to the Royal Dutch Academy of Sciences. Beyond his work as a professor at @TUeindhoven, Luc’s leadership and scientific contributions to the Ambagon team are appreciated and celebrated every day.
1
1
4
Nextech retweeted
9 May 2022
This week our CSO, @NanPry, is at the second Annual Induced Proximity-Based Drug Discovery Summit in Boston to share the latest on Ambagon’s work developing a modular approach to drug discovery. Nancy will speak on Thursday, May 12.
More on this event: bit.ly/3k3j28k
2
2
Nextech retweeted
10 May 2022
We're excited to announce the completion of our Series B financing, advancing our novel #drugdiscovery platform to develop precision medicines for patients in need. Read more here: businesswire.com/news/home/2…
1
5
9
Nextech retweeted
10 May 2022
Fueling the motors!
Great sign of life in this market. Strong science will always get funded. We believe in #biotech. We'll done @moma_tx and great to work with a strong syndicate of @ThirdRockV, Cormorant, @section32vc, @NextechInvest and the new lead @GoldmanSachs
10 May 2022
Working like a machine endpts.com/working-like-a-ma…
1
2
Nextech retweeted
8 Apr 2022
Today we announced clinical data from our ongoing Phase 1/2 clinical trial of CFT7455 for the treatment of multiple myeloma and non-Hodgkin’s lymphomas, to be presented at #AACR22. Read more in our news release: bit.ly/3r8j2aQ
1
3
3